Program 2024
Thursday - Octobre 10
Friday - October 11
08:30
ACCUEIL
thursday
08:50
INTRODUCTION
Franck BLADOU / Wassim KASSOUF
thursday
09:00
JOINT SESSION: Management of histological variants
Chairs: Eva COMPERAT / Laurence ALBIGES
- Prostate cancer – Alexander WYATT
- Bladder cancer – Benjamin PRADERE
- Kidney cancer – Philippe BARTHELEMY
- Discussion
thursday
09:50
Role of systemic intensification at the time of diagnosis of prostate cancer - With the support of BAYER
Chair: Damien POUESSEL
- At localized stage – Bertrand TOMBAL
- At metastatic stage – Guillaume PLOUSSARD
- Discussion
10:35 - 11:00
COFFEE BREAK AND EXHIBITION VISIT
thursday
11:00
BLADDER CANCER
Chairs: Wassim KASSOUF / Vérane ACHARD / Morgan ROUPRET
- Bladder preservation is a SOC in muscle-invasive disease: Yes – Vedang MURTHY / No – Morgan ROUPRET
- BCG unresponsive NMIBC: Systemic – Benjamin PRADERE / Intravesical – Evanguelos XYLINAS
thursday
12:00
Optimizing treatment of genitourinary cancers in 2024 - With the support of ASTELLAS
Chair: Bertrand TOMBAL
- High risk non metastatic BCR or oligometastatic disease? Stephen J FREEDLAND
- NHT monotherapy: from localized to M1 disease. Where do we stand? Bertrand TOMBAL
- Metastatic utothelial carcinoma: New treatments and sequences – Thomas POWLES
- Discussion
13:00 - 14:00
LUNCH AND EXHIBITION VISIT
thursday
14:00
Artificial intelligence and radiotherapy: Where do we stand ?
- Alejandro BERLIN
thursday
14:15
How to achieve complete response in mRCC: Who and when ? With the support of EISAI / MSD
Chair: Philippe BARTHELEMY
- The choice of systemic treatment – Yann VANO
- Place of stereotactic radiotherapy to achieve a complete answer – Mario TERLIZZI
- Favorable IMDC mCCRC: combination for everyone? Philippe BARTHELEMY
- Discussion
thursday
15:15
TESTIS AND PENILE
Chairs: Xavier DURAND / Ludovic FERRETI
- RPLND in germ cell tumors: state-of-the-art – Nicolas DOUMERC
- Brachytherapy for penile cancer: state-of-the-art – Vedang MURTHY
- Discussion
15:45 - 16:15
COFEE BREAK AND EXHIBITION VISIT
thursday
16:15
Urologic cancers: From molecular to clinical application - With the support of JANSSEN
Chairs: Guilhem ROUBAUD / Alexander WYATT
- How is mHSPC landscape evolving? Kim CHI
- mCRPC: how to use PARP inhibitors? Kim CHI
- What’s new in bladder cancer? Yohann LORIOT
- Discussion
thursday
17:15
UROTHELIAL CANCER
Chairs: Delphine BORCHIELLINI / Thomas ZILLI
- Should we intensify upfront BCG treatment in high risk NMIBC – Yohan LORIOT
- Multimodal strategy in locally advanced upper urinary tract carcinoma – Wassim KASSOUF
- Oligometastatic bladder cancer: truth and myths – Thomas ZILLI
thursday
18:00
SPECIAL GUEST
- Ugo MOLA
18:30
FIN
09:00
ACCUEIL
Friday
09:00
Supportive care in Urologic cancers - With the support of IPSEN
Chairs: Carole HELISSEY / Karim BENSALAH
- Role of the Adapted Physical Activity (APA) in the support of urologic cancers – Karim BENSALAH
- mRCC: Optimization of therapeutic care and management of tolerance: What has changed and how this impacts our practices ? Delphine BORCHIELLINI
- How Quality-of-life should guide our treatment decision-making – Carole HELISSEY
Friday
10:00
AFU READ
Chairs: Karim BENSALAH / Alexandre DE LA TAILLE / Andrew LOBLAW
- SBRT for localized renal cancer – Shankar SIVA
- Renaming ISUP1: Yes – Gaëlle FIARD
- Renaming ISUP1: No – Michael BABOUDJIAN
10:30 - 11:00
COFFEE BREAK AND EXHIBITION VISIT
Friday
11:00
Adjuvant treatment in G-U cancers: Where do we stand in 2024? With the support of BMS
Chairs: Paul SARGOS / Laurence ALBIGES / Wassim WASSOUF
- Prostate cancer – Jonathan KHALIFA
- Urothelial cancer – Wassim KASSOUF
- Kidney cancer – Laurence ALBIGES
- Discussion
Friday
12:00
PROSTATE CANCER: Loco-regional treatment of very high risk PCa (STAMPEDE M0)
Chairs: Franck BLADOU / Ronan FLIPPOT / Thomas ZILLI
- Clinical case – Ronan FLIPPOT
- Surgery (and surgical planning for high risk PCa: LND sparing, nerve preservation) – Jochen WALTZ
- Radiotherapy – Andrew LOBLAW
- Discussion
13:00 - 14:00
LUNCH AND EXHIBITION VISIT
Friday
14:00
LOCAL TREATMENT OPTIMIZATION
Chairs: Jochen WALZ / Vedang MURTHY / Shankar SIVA
- Early detection of prostate cancer
- Why we have to do it – Michael BABOUDJIAN
- Why we should better delay the diagnosis – Gaëlle FIARD
- Discussion
- Organ-sparing RC in female patients – Gregory VERHOEST
- How to optimize SBRT in localized Pca – Andrew LOBLAW
- Discussion
Friday
15:00
Nuclear Medicine in G-U cancer: What's new in 2024? With the support of ADACAP
Chairs: Stéphane SUPIOT
- New radiotracers in G-U cancer – Stefan PROBST
- Internal vectorized radiotherapy: earlier is better? M1 – Denis MAILLET
- Internal vectorized radiotherapy: earlier is better? M0 – Thomas SEISEN
- Discussion
Friday
16:00
MUST READ ARTICLE
Chairs : Wassim KASSOUF / Franck BLADOU
- Diego TEYSSONNEAU
Friday
16:15
CONCLUSION
Wassim KASSOUF / Franck BLADOU
